Strategies for Heating Up Cold Tumors to Boost Immunotherapies

Research output: Contribution to journalReview articlepeer-review

Abstract

Immune checkpoint inhibitors induce significant and durable treatment responses in about 20% of all cancers, but many patients have natural resistance to current immunotherapies. The past decade of technological advances has resulted in large-scale profiling of many cancers and their tumor microenvironments, rapidly expanding our understanding of the mechanisms utilized by tumors to create immune-resistant microenvironments. In this review, we discuss key factors that create immune resistance and emerging concepts that are redefining how we view immune resistance, as well as highlight novel strategies that aim to convert immune-resistant into immune-sensitive tumors.

Original languageEnglish (US)
Pages (from-to)149-170
Number of pages22
JournalAnnual Review of Cancer Biology
Volume7
DOIs
StatePublished - Apr 11 2023

Keywords

  • clinical trials
  • immune checkpoint inhibitors
  • immunotherapy
  • tumor microenvironment

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Strategies for Heating Up Cold Tumors to Boost Immunotherapies'. Together they form a unique fingerprint.

Cite this